Delivery Order SPE2DR25D6028-SPE2DR26FARHD
Award Date 11/4/25
Potential Completion Date 12/3/25
Potential Value $2.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $9,215.11 for the supply of 4,564,158,437 units of Colchicine 0.6 mg capsules. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 4, 2024. The contract is a firm fixed-price type, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, with ID SPE2DB20D2104|SPE2DB25FMDNV, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,445.09 firm fixed-price delivery order is for the supply of 4566640101 - Colchicine 0.6 mg capsules in 100-count bottles. The contract has an ultimate completion date of December 9, 2024 and was awarded on December 6, 2024. AmerisourceBergen holds a significant $999,999,999...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on September 10, 2025, with a ceiling value of $9,727.86. This firm fixed-price delivery order, which represents a child contract under a larger vehicle, is scheduled for completion by September 11, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded a $21,382.17 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for Columvi 10 mg/10 mL vials. This is a firm fixed-price, competitively awarded contract with performance to be completed by August 27, 2025, at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under a larger indefinite delivery contract vehicle. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $1,152.00 from the Defense Logistics Agency's Medical Supply Chain on September 15, 2025. The award is structured as a firm fixed price delivery order with no set-aside designation, reflecting competitive procurement practices. The contract's ultimate completion date is September 16, 2025, and performance will be executed at the vendor's Conshohocken...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,976.34 to AmerisourceBergen Drug Corp on August 16, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the prime contractor under its existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $44,402.40 by the Defense Logistics Agency's Medical Supply Chain on August 14, 2025. This non-competitive, firm fixed-price delivery order is effective through August 15, 2025, and represents a child award issued under a larger contract vehicle. The award demonstrates the contractor's capability to meet federal pharmaceutical procurement...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for pharmaceutical and medical supply products valued at $14,620.64. This non-competitive, firm fixed-price delivery order is scheduled for completion by September 30, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical supplier to federal...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for pharmaceutical and medical supply products valued at $1,386.84. This firm fixed-price delivery order, with an ultimate completion date of August 6, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical. The award was made through open competition with no set-aside designation....
- The Defense Logistics Agency awarded a $52,869.34 delivery order to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of Columvi 10 mg/10 mL vials. This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania, and an ultimate completion date of October 20, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...